Research.Patient.info
mature B-Cell malignancies research hub
2 indexed studies · 1 currently recruiting
- recruitingHuman Pharmacology (Phase I)- First administration to humans
A Phase 1/1b Open-Label Dose-Escalation and Dose-Optimization Study of Bcl-2 Inhibitor BGB 21447 in Patients With Mature B Cell Malignancies
This study is testing a new medicine called BGB 21447 for people with certain types of blood cancer. Researchers want to find the safest and best dose of this medicine to help treat these conditions.
France · Italy - active not recruitingPHASE1
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies
This study is testing a new medicine called sonrotoclax for certain blood cancers like lymphoma and leukaemia. We want to find the safest and most effective dose, both on its own and when combined with other medicines, to help patients with these conditions.
United States · Australia · Germany